Biochips (Microarrays/Micr ofluidics)
Market
Biochips (Microarrays/Microfluidics) Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Biochips (Microarrays/Microfluidics) Market Size and Growth
The biochips market, encompassing microarrays and microfluidics, is experiencing substantial growth driven by advancements in personalized medicine and genomics. The global biochips market size was valued at approximately $9 billion in 2023, with projections indicating continued expansion due to rising demand for diagnostic and therapeutic applications in healthcare.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Agilent
◍ PerkinElmer
◍ Fluidigm
◍ Illumina
◍ GE Healthcare
◍ Bio-Rad Laboratories
◍ Cepheid
◍ Thermo Fisher
◍ Roche
The biochips market features key players like Abbott, Agilent, PerkinElmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad, Cepheid, Thermo Fisher, and Roche. They leverage microarrays and microfluidics for diagnostics, research, and personalized medicine, driving innovation and market growth. Specific revenue figures are proprietary and cannot be disclosed.
Request Sample Report
Market Segmentation
By Application
Academics Institutes
Diagnostics Centers
Request Sample Report
By Product
DNA Chip
Lab-on-a-chip
Protein Chip
Market Growth
Request Sample Report
$ X Billion USD
